AVEO | AVEO Pharmaceuticals (NASDAQ:AVEO) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research downgraded shares of AVEO Pharmaceuticals (NASDAQ:AVEO) from a buy rating to a hold rating in a report released on Monday morning, Zacks.com reports.According to Zacks, “AVEO Pharmaceuticals, Inc.is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics.Its product candidates are targeted against important mechanisms known or […]Daily Political